Skip to main content
CreoSG Co.,Ltd. logo

CreoSG Co.,Ltd. — Investor Relations & Filings

Ticker · 040350 ISIN · KR7040350001 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 355 across all filing types
Latest filing 2023-12-28 Major Shareholding Noti…
Country KR South Korea
Listing KO 040350

About CreoSG Co.,Ltd.

https://www.creosg.com/

CreoSG Co., Ltd. is a company with two primary business divisions: IT solutions and biotechnology. The IT solutions division specializes in providing services to financial institutions, focusing on the development and implementation of next-generation systems, application development, and IT outsourcing. The biotechnology division is dedicated to the research and development of vaccines. Its main pipeline includes an HIV/AIDS vaccine candidate and a COVID-19 vaccine. The company's vaccine development is based on its proprietary recombinant Vesicular Stomatitis Virus (VSV) vector system, which serves as its core technological platform.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is titled '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under Article 147 of the Capital Markets Act. It details the shareholding status, changes in ownership, and the purpose of holding (management influence) for (주)큐로컴. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2023-12-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is specifically used to report changes in share ownership by insiders or major shareholders, which falls under the 'Director's Dealing' category in the provided classification schema.
2023-12-28 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Securities Issuance Result' (증권 발행결과) announcement from Curocom, detailing the completion of a third-party capital increase (유상증자). It specifies the number of shares issued, the amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2023-12-19 Korean
최대주주변경
Major Shareholding Notification Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system regarding a 'Change in Largest Shareholder' (최대주주변경). It details the shift in shareholding structure, the identity of the new largest shareholder, the reason for the change (third-party capital increase), and financial details of the new controlling entity. This falls under the category of general regulatory announcements and corporate disclosures that do not fit into specific categories like M&A or Director's Dealing, making 'Regulatory Filings' (RNS) the most appropriate classification.
2023-12-19 Korean
[기재정정]최대주주변경
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding a 'Change in Largest Shareholder' (최대주주변경). It details the shift in ownership structure due to a third-party capital increase, including specific share counts, percentages, and the identity of the new controlling entity. Since this is a specific regulatory disclosure regarding corporate control and shareholding structure that does not fit into the other specialized categories like 'Director's Dealing' or 'Major Shareholding Notification' (which usually refers to external investors), it is classified as a Regulatory Filing (RNS).
2023-12-19 Korean
최대주주변경을수반하는주식담보제공계약해제ㆍ취소등
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding the cancellation or release of a stock collateral agreement involving a change in the largest shareholder. This type of disclosure is a specific regulatory requirement for listed companies to report changes in collateral status that could impact ownership control. Since it does not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Major Shareholding Notification' (which is for threshold crossings), and it is a formal regulatory disclosure of a corporate event, it is best classified as a Regulatory Filing (RNS).
2023-12-19 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.